Heat therapy for hard-to-treat gout
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests if heat therapy can help people with gout that doesn't get better with standard treatments. It aims to reduce flare-ups and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with refractory gout, meaning your uric acid stays high despite taking medication, you have frequent flares, or you have tophi (hard lumps under the skin)
- You have had at least three gout attacks in the past year
- You do not have an active gout flare within the last 2 weeks
- You do not have other serious health conditions like heart, lung, liver, kidney disease, or active infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called IN026 for people with refractory gout—gout that doesn't respond well to current treatments and causes severe symptoms. The goal is to see if IN026 can lower uric acid levels and reduce gout attacks.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This trial checks if testing for a specific gene (HLA-B*58:01) before starting gout medication can prevent severe allergic reactions. It compares standard care with a gene-guided approach to see which is safer and works better.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
Hear when a new Refractory Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.